Skip to main content
Clinical Trials/IRCT20161207031288N12
IRCT20161207031288N12
Recruiting
Phase 2

Safety and effectiveness assessment of Dermavisc deep, injectable gel for nasolabial folds correction

Pouragen Company0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Pouragen Company
Enrollment
30
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Pouragen Company

Eligibility Criteria

Inclusion Criteria

  • 18 \-65 years old men and women
  • Moderate to severe nasolabial folds based on Allergan criteria
  • The opportunity to accompany the visit programs and study process.
  • Signing the infirmed consent form and agree to a 9\-month follow\-up

Exclusion Criteria

  • Previous hyaluronic acid (HA)\-based dermal filler treatment(s) injected within the last 12 months prior to enrollment
  • Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non\-ablative procedures), Botox) in the lower 2/3 of the face, within 3 month prior to study entry
  • Planning to undergo any of these procedures at any time during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials